Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7095 studies found for:    insulin
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Humalog;   Drug: Humulin-R;   Drug: Recombinant human hyaluronidase PH20 (rHuPH20);   Other: Liquid meal
2 Completed
Has Results
Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20
Condition: Diabetes Mellitus
Interventions: Drug: Humalog;   Drug: Humulin-R;   Drug: Recombinant human hyaluronidase PH20 (rHuPH20)
3 Completed
Has Results
Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Humalog;   Drug: Humulin-R;   Drug: Recombinant human hyaluronidase PH20 (rHuPH20)
4 Recruiting Regulation of Endogenous Glucose Production by Brain Insulin Action
Condition: Insulin Resistance, Diabetes
Intervention: Drug: Intranasal insulin
5 Unknown  Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin;   Drug: human insulin;   Drug: Insulin Glargine;   Drug: Insulin glulisine
6 Completed
Has Results
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Regular Human Insulin;   Drug: rHuPH20
7 Enrolling by invitation Comparison Study of Insulin Glargine and NPH Insulin
Condition: Diabetes
Interventions: Drug: Switching to NPH insulin;   Drug: Continuation of insulin glargine
8 Completed Topic Insulin Accelerates Wound Healing in Diabetes
Conditions: Diabetes Mellitus;   Wounds
Intervention: Drug: topic cream insulin
9 Completed Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Long-acting bedtime insulin detemir (Levemir);   Drug: Insulin detemir and pre-meal insulin aspart.
10 Not yet recruiting Self-management of Type 1 Diabetes Under Functional Insulin Therapy
Conditions: Type 1 Diabetes;   Basal-bolus Multiple-dily Insulin Injections;   Insulin Pump (CSII)
Interventions: Other: Training course to functional insulin therapy;   Other: Usual diabetes management.
11 Completed
Has Results
Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
Condition: Diabetes Mellitus
Interventions: Drug: MDI (split-mix NPH insulin + regular insulin or Lantus + Novolog® [or Humalog®]);   Device: CSII (Animas Corporation insulin pump, model IR 1200)
12 Not yet recruiting PK/PD STUDY OF U-500 REGULAR INSULIN
Conditions: Type 2 Diabetes;   Insulin Resistance;   High Insulin Requirements
Intervention: Drug: U-500 insulin
13 Completed
Has Results
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Lispro Low Mixture (LM);   Drug: Insulin Glargine;   Drug: Prandial Insulin Lispro
14 Enrolling by invitation Insulin Infusion Diabetes Ulcer
Conditions: Diabetes Mellitus;   Insulin Resistance;   Hyperglycemia;   Surgery;   Ulcers;   Infection
Intervention: Procedure: Insulin infusion
15 Recruiting Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Condition: Type 2 Diabetes
Interventions: Drug: Basal insulin and exenatide;   Drug: Basal insulin only;   Drug: Basal insulin and bolus insulin
16 Completed Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Regular insulin (Humulin);   Drug: Insulin lispro (Humalog)
17 Suspended Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: Regular Insulin
18 Completed Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Oral insulin;   Drug: regular human insulin
19 Completed
Has Results
Comparison of Insulins Aspart and Lispro in Insulin Pumps
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin Aspart;   Drug: Insulin Lispro
20 Unknown  The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years